Effects of Blocking Blue Light At Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH
Launched by WEST VIRGINIA UNIVERSITY · Sep 30, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether reducing blue light exposure at night can help patients recover better after heart surgeries, such as bypass surgery (CABG) or valve replacements (AVR and MVR). The researchers believe that filtering out blue light could lower inflammation in the body, improve mood, and enhance sleep quality, which might lead to quicker recoveries and fewer complications. The goal is to see if this simple change in hospital lighting can make a big difference in patient outcomes and potentially lower healthcare costs.
To participate in this trial, you need to be an adult undergoing elective heart surgery, without any significant psychiatric disorders or organ failures. If you qualify, you can expect to be part of a study that monitors your recovery process while using special light filters at night. This research could lead to valuable insights on how light affects healing and overall well-being after surgery, making it an important opportunity for patients and the healthcare community alike.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both men and women that are undergoing elective (non-emergency)
- • on-pump CABG surgery,
- • AVR,
- • MVR,
- • CABG AVR,
- • CABG MVR or
- • SAH
- • No history of diagnosed psychiatric disorders or organ failure
- Exclusion Criteria:
- • Evidence or diagnosis of dementia or other cognitive deficit
- • Diagnosed psychiatric disorder (including depression and anxiety)
- • Organ failure \[kidney (creatine \> 1.5 mg/dL), liver, etc.\]
- • Chronic obstructive pulmonary disease,
- • Any immune disorder
- • Acute infection
- • Prior cardiac surgery
- • Elective aneurysms
- • Combined cardiac operations
- • Left main stenosis greater than 70%
- • Left ventricular ejection fraction (LVEF) lower than 0.5
- • Any condition that increases likelihood of the need for a blood transfusion during or after the surgery
- • Clotting disorder
- • Suspected less than 8th grade English reading comprehension level
About West Virginia University
West Virginia University (WVU) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a strong commitment to improving patient outcomes, WVU harnesses its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies across a wide range of medical fields. The university collaborates with healthcare providers, industry partners, and regulatory bodies to ensure the highest standards of ethics and scientific integrity in its research endeavors. WVU strives to translate scientific discoveries into practical applications, ultimately enhancing the quality of care for diverse populations in West Virginia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Morgantown, West Virginia, United States
Patients applied
Trial Officials
Randy J Nelson, PhD
Principal Investigator
West Virginia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials